Pediatric Neurology
Volume 28, Issue 1 , Pages 48-52, January 2003

Reduction of seizures with low-dose clonazepam in children with epilepsy

  • Maria G Dahlin, MD, PhD

      Affiliations

    • Department of Pediatrics, Astrid Lindgren Children’s Hospital, Stockholm, Sweden
    • Corresponding Author InformationCommunications should be addressed to: Dr. Dahlin; Neuropediatric Department; Astrid Lindgren Children’s Hospital; Karolinska Hospital; SE-171 76 Stockholm, Sweden.
  • ,
  • Per E Åmark, MD, PhD

      Affiliations

    • Department of Pediatrics, Astrid Lindgren Children’s Hospital, Stockholm, Sweden
  • ,
  • Arne R Nergårdh, MD, PhD

      Affiliations

    • Department of Pediatrics, Astrid Lindgren Children’s Hospital, Stockholm, Sweden
    • Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden

Received 2 April 2002; accepted 27 June 2002.

Abstract 

The acute effects of low-dose clonazepam on seizure frequency in children with epilepsy was evaluated. In an open study, 19 children with epilepsy (15 generalized and four partial) were examined during hospitalization with recordings of seizures by trained personnel. Seizures were counted during two 24-hour periods: before and after a single intramuscular injection of clonazepam 0.01-0.04 mg/kg body weight. Plasma concentrations of clonazepam were determined. The median number of seizures in all children on control days was 22 (range = 1-180) and, on days after low-dose clonazepam, the median was 6 (range = 0-73). The relative changes demonstrated a median of –70% (range from –100% to + 43%). A significant reduction of seizures (P = 0.0031) at median maximal plasma levels of clonazepam of 23 nmol/L (range = 11-41 nmol/L) was found. Thus in this study of the acute effects of a low-dose level of clonazepam on seizure frequency a significant reduction was found at plasma levels below those usually recommended. Inhibition of seizure activity seems to be achieved already at low plasma levels of clonazepam. These results suggest to start treatment at low doses of clonazepam and evaluate the individual effect carefully during dose escalation aiming at lowest possible dose with therapeutic effect.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(02)00468-X

doi:10.1016/S0887-8994(02)00468-X

Pediatric Neurology
Volume 28, Issue 1 , Pages 48-52, January 2003